SCHEMBL14009098

SCHEMBL14009098

CN(C)CCNC(=O)c1ccc(C(=O)Nc2ccc(-n3cncn3)cc2)s1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 1/20 0.48
▸ S1PR1 P21453 1/20 0.44
▸ AKT3 Q9Y243 1/20 0.41
▸ HTR2C P28335 1/20 0.41
▸ NAMPT P43490 3/20 0.41
▸ NPC1 O15118 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ ROCK1 Q13464 1/20 0.40
▸ PDE7A Q13946 1/20 0.39
▸ ROCK2 O75116 1/20 0.38
▸ ICAM1 P05362 1/20 0.38
▸ SELE P16581 1/20 0.38
▸ VCAM1 P19320 1/20 0.38
▸ ATM Q13315 2/20 0.37
▸ CA2 P00918 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ IKBKB O14920 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14009196 0.94 NAMPT (0.43) MAPK1S1PR1NAMPTNPC1RAB9A
SCHEMBL14009086 0.84 S1PR1 (0.42) S1PR1HTR2CRAB9AROCK1PDE7A
SCHEMBL14009094 0.84 ROCK1 (0.42) S1PR1NAMPTNPC1RAB9AROCK1
SCHEMBL14009176 0.83 ROCK1 (0.41) S1PR1NAMPTNPC1RAB9AROCK1
SCHEMBL14009139 0.82 HDAC1 (0.49) AKT3NAMPTNPC1RAB9AROCK1
SCHEMBL14609404 0.82 ROCK1 (0.45) S1PR1NPC1RAB9AROCK1ICAM1
SCHEMBL14009084 0.82 NAMPT (0.44) S1PR1NAMPTNPC1RAB9AROCK1
SCHEMBL14009122 0.82 S1PR1 (0.41) S1PR1RAB9AROCK1ROCK2ICAM1
SCHEMBL14009163 0.81 ROCK1 (0.51) S1PR1NPC1RAB9AROCK1ICAM1
SCHEMBL14009349 0.81 ROCK1 (0.46) S1PR1NPC1RAB9AROCK1ICAM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7446195-B2 High affinity thiophene-based and furan-based kinase ligands SCHERING CORPORATION (US) 2008-11-04 — — US disclosed
US-7446195-B2 High affinity thiophene-based and furan-based kinase ligands SCHERING CORPORATION (US) 2008-11-04 — — US disclosed
US-20070043045-A1 Novel high affinity thiophene-based and furan-based kinase ligands SCHERING CORPORATION 2007-02-22 — — US disclosed
US-20070043045-A1 Novel high affinity thiophene-based and furan-based kinase ligands SCHERING CORPORATION 2007-02-22 — — US disclosed
WO-2007022258-A1 NOVEL HIGH AFFINITY THIOPHENE-BASED AND FURAN-BASED KINASE LIGANDS SCHERING CORPORATION (US) 2007-02-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070043045-A1 Novel high affinity thiophene-based and furan-based kinase ligands CDKL2, CDK2, CDKL1 MAPK1 356/4885S1PR1 2163/4885AKT3 1040/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback